This study is testing the effectiveness of the investigational use of intravenous iron in subjects with unexplained anemia.
Who is eligible?
Age ≥ 65 years old
Hb concentration ≥ 9.0 g/dL and < 11.5 g/dL (women) or < 12.7 g/dL (men)
Serum ferritin level ≥ 20 and ≤ 100 ng/mL
Unexplained anemia
Able to walk on own without the use of assistance
Able to understand and speak English
Whenand Where? Recruitment and enrollment is currently open. Study visits will occur at the UCLA Anemia Clinic and at UCLA's Clinical and Translational Research Center (CTRC).
Whois conducting the study? David Reuben Chief of Geriatrics David Geffen School of Medicine, Division of Geriatrics
Who to contactif you are interested in participating in this study:
Karina Ramirez, Study Coordinator Phone: 310-267-0845 Email:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it